IP Verse

Pfizer Ireland Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Pfizer Ireland Pharmaceuticals opposed by its competitors

Explore Pfizer Ireland Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3269717
Aug 9, 2023Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl1041
EP2357250
Oct 6, 2021Production Of Polypeptides2
EP1789571
Apr 26, 2017Production Of Polypeptides2

Latest publications and patents of Pfizer Ireland Pharmaceuticals New

Explore the latest publications and patents granted to Pfizer Ireland Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Pfizer Ireland Pharmaceuticals

EP3269717
Aug 9, 2023Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104Patent Maintained As Amended
EP2357250
Oct 6, 2021Production Of PolypeptidesRevoked
EP1789571
Apr 26, 2017Production Of PolypeptidesRevoked

Latest PTAB cases involving Pfizer Ireland Pharmaceuticals

Discover the latest PTAB cases involving Pfizer Ireland Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Pfizer Ireland Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PFIZER IRELAND PHARMACEUTICALS - 5 - -
BREUER16 - - -
JAMES POOLE153 - - -
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB17 - - -